Method for determining sensitivity to sglt2 inhibitor and sensitivity marker for sglt2 inhibitor
AssigneesNihon University, Osaki City, Nippon Kayaku Kabushiki Kaisha
InventorsTadateru TAKAYAMA, Masahiro USUI, Keiko KUDO
Life of this patent
Estimating the term…
Abstract
The object of the present invention is to provide a method for determining the sensitivity of a subject to an SGLT2 inhibitor, and a sensitivity marker for the SGLT2 inhibitor. The present invention provides a method for determining the sensitivity of a subject to an SGLT2 inhibitor, comprising measuring a biomarker in the biological sample of a subject, and determining the sensitivity of the subject to the SGLT2 inhibitor using the measured biomarker value as an indicator.
Claims20
A method for treating diabetes comprising the steps of:
- measuring a biomarker in the biological sample of a subject to determine a sensitivity of the subject to an SGLT2 inhibitor using the measured biomarker value as an indicator;
- and
- administering the SGLT2 inhibitor to the subject which was determined to have a sensitivity to the SGLT2 inhibitor.
A method for determining a sensitivity to an SGLT2 inhibitor comprising the steps of:
- measuring a biomarker in the biological sample of a subject;
- and
- using the measured biomarker value as an indicator.
Dependencies are inferred from the claim text.